PharmaRoth Labs, Inc. Stock Other OTC
Equities
ROTH
US71715Y1029
Pharmaceuticals
Financials (USD)
Sales 2009 | - | Sales 2010 | - | Capitalization | 5.74M |
---|---|---|---|---|---|
Net income 2009 | - | Net income 2010 | - | EV / Sales 2009 | - |
Net Debt 2009 | 12.5K | Net Debt 2010 | 286K | EV / Sales 2010 | - |
P/E ratio 2009 |
-777
x | P/E ratio 2010 |
-7.8
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 30.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 | |
Barry W. Hall
DFI | Director of Finance/CFO | 76 | 13-01-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 |
1st Jan change | Capi. | |
---|---|---|
+25.61% | 660B | |
+23.19% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.64% | 219B | |
-9.69% | 196B | |
+6.69% | 199B | |
-8.75% | 149B |